Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LALBA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GNAO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KRT8P12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FRRS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1G1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RY10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00926 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929726 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSG1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFCAB11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on